JPRN-UMIN000020806尚未招募未知
The effect of rivaroxaban for hemodynamics in left atrium and thrombotic / thrombolytic biomarkers - The effect of rivaroxaban for hemodynamics in left atrium and thrombotic / thrombolytic biomarkers
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •paroxysmal atrial fibrillation obvious thrombus in LA or LAA cardiac tumor including myxoma contraindication of rivaroxaban creatinine clearance under 30ml/min unstable blood pressure control unstable control of blood sugar heart failure functional class NYHA 3 or 4 other unsuitable situation for this study
研究者
相似试验
招募中
2 期
Assessment of the impact of Rivaroxaban in peripheral artery disease (PAD) of the lower extremitiesIRCT20231117060086N1Ahvaz University of Medical Sciences112
招募中
不适用
Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patientsatrial fibrillationJPRN-UMIN000011129Yokohama Sakae Kyosai Hospital50
招募中
2 期
Treatment with rivaroxaban compared with warfarin in patients with acute coronary syndromeAcute coronary syndrome.Other acute ischemic heart diseasesIRCT20210614051574N9Esfahan University of Medical Sciences60
尚未招募
不适用
Study on use of rivaroxaban along with aspirin in the management of coronary heart disease problemCTRI/2021/08/035826Dr Viveka Kumar
已完成
不适用
A Prospective Pharmacodynamic Study of RivaroxabanBlood ClotNCT01743898University of North Carolina, Chapel Hill65